Angion Biomedica Corp. Separation Agreements
3 Contracts & Agreements
- Amended and Restated Executive Separation Benefits Plan dated November 19, 2021 (Filed With SEC on March 30, 2022)
- Separation Agreement, dated March 1, 2022, by and between Angion Biomedica Corp. and Elisha Goldberg (Filed With SEC on March 30, 2022)
- Separation Agreement, dated February 25, 2022, by and between Angion Biomedica Corp. and Itzhak D. Goldberg (Filed With SEC on March 30, 2022)
